ESOT The European Society
for Organ Transplantation

What can we help you find?

Leading the way in transplantation

Filter results for:

Don't need the search bar? Close it here

Search Results for:

The Science of ECP in Solid Organ Transplantation | ESOT

Extracorporeal Photopheresis (ECP) continues to generate discussion across solid organ transplantation, particularly in the context of chronic rejection and immune modulation. ESOT’s on-demand Transplant Live programme explores the scientific rationale, clinical evidence and organ-specific applications of ECP in heart, lung and kidney transplantation.​ With expert insights covering mechanisms of action, chronic lung allograft dysfunction (CLAD),

Living with CLAD: Free Webinar on Chronic Lung Allograft Dysfunction After Lung Transplantation​

Chronic Lung Allograft Dysfunction (CLAD) remains one of the most serious long-term complications after lung transplantation. While transplantation can be life-saving,CLAD presents ongoing medical, physical, and emotional challenges for patients, caregivers, and healthcare professionals.​ ​ Join our upcoming free webinar in the CLAD series!​ This expert-led session will provide an updated overview of the burden of CLAD, focusing

Apply Now: Transplant Science Summer School 2026

We are pleased to announce that applications for the Transplant Science Summer School 2026 are now open. This event will take place from 11 to 13 June in Krakow, Poland, providing an excellent opportunity for learning and collaboration in the field.  The Transplant Science Summer School is a 2½-day in-person course for early-career professionals who are interested in a future in transplant science.

ESOT Launches the European Pancreas and Islet Transplant Registry (EPITR)

EPITR is the result of years of collaboration and careful learning. We have built a registry that advances science while putting data protection, ethical governance, and patient safety at its core. This balance is essential if real-world data is to truly serve patients and guide the future of transplantation. Devi Mey, ESOT CEO